Mild to Moderate Iron-Deficiency Anemi
Conditions
Interventions
Sponsors
Shaanxi Provincial Hospital of Traditional Chinese Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 45 Years
Inclusion criteria
Inclusion criteria: (1) Age 18-45 years, female; (2) Participants with microcytic hypochromic anemia with confirmed iron deficiency etiology and clinical manifestations; (3) Meeting the diagnostic criteria for mild to moderate iron deficiency anemia (hemoglobin 85-110 g/L); (4) With normal liver and kidney function; (5) Volunteers who have provided written informed consent.
Exclusion criteria
Exclusion criteria: (1) Participants with severe diseases of the heart, cerebrovascular, liver, kidney, digestive tract, or psychiatric disorders; (2) Participants with other types of anemia (e.g., thalassemia, megaloblastic anemia) or diseases affecting iron metabolism (e.g., chronic inflammation, tumors); (3) Allergic constitution or allergy to the test sample; (4) Participants with severe anemia; (5) Participants who have taken medications or supplements to improve blood condition (e.g., iron supplements, vitamin C, vitamin B12, folic acid) in the past month, which may affect the results; (6) Pregnant or breastfeeding women; (7) Participants who have participated in other clinical trials in the past 3 months; (8) Participants who did not take the test sample as required or have incomplete data affecting efficacy or safety evaluation; (9) Participants who, in the researcher's opinion, cannot fully comply with the trial arrangements.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Hemoglobin; | — |
Secondary
| Measure | Time frame |
|---|---|
| Red blood cell parameters: Mean corpuscular volume (MCV), Mean corpuscular hemoglobin (MCH), Mean corpuscular hemoglobin concentration (MCHC), Red blood cell count (RBC);Iron metabolism indicators: Serum iron (SI), Serum ferritin (SF), Total iron-binding capacity (TIBC), Transferrin saturation (TSAT), Soluble transferrin receptor (sTfR);Hypersensitive C-reactive protein (hs-CRP);Blood glucose level testing: fasting blood glucose, postprandial blood glucose at 0.5h, 1h, 2h, 3h, and 4h;Clinical Symptoms Improvement Scale;Women's Qi and Blood Health Questionnaire; | — |
Countries
China
Contacts
Public ContactYin Wei
Shaanxi Provincial Hospital of Traditional Chinese Medicine
Outcome results
None listed